BKD enters its Q2 print today with the stock down 5% on the week, yet options traders remain conspicuously unbothered by the slide.
The call-side tilt that defined the pre-earnings setup five days ago has not reversed. The put/call ratio is running at 0.36 — still more than a standard deviation below its 20-day average of 0.62 — keeping it near the lowest defensive reading of the past year. That's a notable signal given the stock has shed nearly 5% over the past month to $13.69. Options positioning is not reflecting the price weakness; traders continue to lean toward upside rather than hedging into the number. The cost to borrow has spiked sharply in the past week — more than doubling to 1.24% — though it remains low in absolute terms. Borrow availability is ample at roughly 879% of short interest, meaning there is no meaningful squeeze pressure in the lending pool.
Short interest is the structural weight hanging over the thesis. Bears hold 15.7% of the free float — genuinely elevated — though the position has been grinding slowly smaller, down roughly 1.2% over the past month. That directional drift matters: shorts are not adding conviction into this print. The ORTEX short score sits at 62, in the bottom quartile of the universe by short-score rank, reflecting the combination of high but slowly easing SI and loose borrow conditions. The contradiction between the bearish structural positioning and the bullish options lean is the defining tension heading into today's release.
Analysts are firmly in the bull camp, with four buy-equivalent ratings and a consensus target near $19.58 — implying more than 40% upside from current levels. The bull case rests on occupancy momentum: June's weighted average occupancy reached 80.5%, up 230 basis points year-over-year, with sequential gains driven by higher move-ins. Bears counter that margin expansion is fragile, pointing to elevated labor costs and roughly $1.45 billion in interest rate caps and swaps expiring within the year. The stock has a history of punishing misses — the prior two quarterly prints both produced one-day drops exceeding 4%, with the May report falling more than 8% over the following five days. Barclays has maintained an Overweight rating with a $18 target, and Compass Point initiated at Buy with a $22 target in June, though both sit well above where the stock trades today.
The print is therefore a test of whether the occupancy trajectory is translating into the EBITDA inflection that justifies a re-rating — or whether cost pressures are absorbing the revenue gains faster than the bull case assumes.
See the live data behind this article on ORTEX.
Open BKD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
